Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Hugo measured Gene Rank description expected final
Results: HTML CSV LaTeX
Showing element 2608 to 2657 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
final\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SEC61A1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1.32564\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1954\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
PROTEIN TRANSPORT PROTEIN SEC61 ALPHA SUBUNIT ISOFORM 1 (SEC61 ALPHA- 1). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5.73234\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.231256346\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SEC61A2\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1.30722\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1957\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
PROTEIN TRANSPORT PROTEIN SEC61 ALPHA SUBUNIT ISOFORM 2 (SEC61 ALPHA- 2). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5.6527\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.23125586\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SEC61G\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.114962\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2031\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
PROTEIN TRANSPORT PROTEIN SEC61 GAMMA SUBUNIT. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.499271\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.230259719\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SEPHS1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0620748\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
102\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"SELENIDE,WATER DIKINASE 1 (EC 2.7.9.3) (SELENOPHOSPHATE SYNTHETASE 1) (SELENIUM DONOR PROTEIN 1). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.166067\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.37379371\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SEPHS2\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0447647\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
103\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"SELENIDE,WATER DIKINASE 2 (EC 2.7.9.3) (SELENOPHOSPHATE SYNTHETASE 2) (SELENIUM DONOR PROTEIN 2). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.119758\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.373792983\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SEPSECS\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.293391\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1047\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SOLUBLE LIVER ANTIGEN/LIVER PANCREAS ANTIGEN. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16068\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.252775097\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SEPT1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0798252\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2963\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SEPTIN 1 (LARP) (SEROLOGICALLY DEFINED BREAST CANCER ANTIGEN NY-BR- 24). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.547429\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.145818362\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SEPT10\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.106813\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3022\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SEPTIN 10 ISOFORM 1. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.88182\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.121127895\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SEPT11\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.136179\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3007\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08705\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.125273906\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SEPT4\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.16041\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2989\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SEPTIN 4 (PEANUT-LIKE PROTEIN 2) (BRAIN PROTEIN H5) (CELL DIVISION CONTROL-RELATED PROTEIN 2) (HCDCREL-2) (BRADEION BETA) (CE5B3 BETA) (CEREBRAL PROTEIN-7) (HUCEP-7). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17491\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.136529607\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SEPT6\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.116797\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3008\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SEPTIN 6. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.952641\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.122603373\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SEPT7\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.09144\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3009\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SEPTIN 7 (CDC10 PROTEIN HOMOLOG). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.749104\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.122065828\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SEPT8\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.118014\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3023\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SEPTIN-LIKE PROTEIN KIAA0202 (FRAGMENT). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.986632\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.119612986\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SERBP1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0417836\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1311\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.170042\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.245725174\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SERINC1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0257797\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2417\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
TUMOR DIFFERENTIALLY EXPRESSED 1 PROTEIN LIKE. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.118068\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.218346207\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SERINC2\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0249219\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2414\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
TUMOR DIFFERENTIALLY EXPRESSED PROTEIN 2. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.114139\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.218346928\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SERINC3\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0298377\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2415\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
TUMOR DIFFERENTIALLY EXPRESSED PROTEIN 1 (TRANSMEMBRANE PROTEIN SBBI99). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.136653\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.218346469\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SERPINB1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0244744\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2319\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
LEUKOCYTE ELASTASE INHIBITOR (LEI) (MONOCYTE/NEUTROPHIL ELASTASE INHIBITOR) (M/NEI) (EI). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.110346\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.221796893\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SERPINB10\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0196713\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2322\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
BOMAPIN (PROTEASE INHIBITOR 10) (SERPIN B10). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.088691\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.221795898\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SERPINB12\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0598165\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1577\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SERPIN B12. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.248312\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.240892506\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SERPINB4\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0820308\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1580\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SQUAMOUS CELL CARCINOMA ANTIGEN 1 (SCCA-1) (PROTEIN T4-A). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.340529\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.240892259\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SERPINB6\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0199527\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2327\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
PLACENTAL THROMBIN INHIBITOR (CYTOPLASMIC ANTIPROTEINASE) (CAP) (PROTEASE INHIBITOR 6) (PI-6). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.0899599\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.221795489\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SERPINB7\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.056548\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1581\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
MEGSIN (TP55) (SERPIN B7). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.234744\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.240892206\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SERPINB8\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0198854\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2328\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
PLASMINOGEN ACTIVATOR INHIBITOR-2 PRECURSOR (PAI-2) (PLACENTAL PLASMINOGEN ACTIVATOR INHIBITOR) (MONOCYTE ARG-SERPIN) (UROKINASE INHIBITOR). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.0896565\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.221795408\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SERPINB9\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0200935\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2321\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
CYTOPLASMIC ANTIPROTEINASE 3 (CAP3) (CAP-3) (PROTEASE INHIBITOR 9) (SERPIN B9). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.0905944\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.22179627\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SERPINC1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0555356\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1585\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ANTITHROMBIN-III PRECURSOR (ATIII) (PRO0309). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230542\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.240891464\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SESN1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.699473\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
622\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SESTRIN 1 (P53-REGULATED PROTEIN PA26). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.60745\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.268259411\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SESN2\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.553815\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
628\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SESTRIN 2 (HI95). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.06448\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.268258835\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SESN3\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.578823\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
635\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SESTRIN 3. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.15771\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.268258014\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SETD3\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0346049\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2436\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.159272\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.2172692\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SETMAR\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.379831\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3014\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SET DOMAIN AND MARINER TRANSPOSASE FUSION GENE. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3.11762\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.121833642\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SF3A1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.894103\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
339\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SPLICING FACTOR 3 SUBUNIT 1 (SPLICEOSOME ASSOCIATED PROTEIN 114) (SAP 114) (SF3A120). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3.13898\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.284838706\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SF3A2\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.374541\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
298\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SPLICING FACTOR 3A SUBUNIT 2 (SPLICEOSOME ASSOCIATED PROTEIN 62) (SAP 62) (SF3A66). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.24681\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.300399419\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SF3A3\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0420473\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
340\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SPLICING FACTOR 3A SUBUNIT 3 (SPLICEOSOME ASSOCIATED PROTEIN 61) (SAP 61) (SF3A60). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.147618\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.28483857\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SF3B1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.764466\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
225\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SPLICING FACTOR 3B SUBUNIT 1 (SPLICEOSOME ASSOCIATED PROTEIN 155) (SAP 155) (SF3B155) (PRE-MRNA SPLICING FACTOR SF3B 155 KDA SUBUNIT). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.41141\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.317020333\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SF3B2\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.557721\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
275\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SPLICING FACTOR 3B SUBUNIT 2 (SPLICEOSOME ASSOCIATED PROTEIN 145) (SAP 145) (SF3B150) (PRE-MRNA SPLICING FACTOR SF3B 145 KDA SUBUNIT). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.82999\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.304767239\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SF3B4\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0893365\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
363\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SPLICING FACTOR 3B SUBUNIT 4 (SPLICEOSOME ASSOCIATED PROTEIN 49) (SAP 49) (SF3B50) (PRE-MRNA SPLICING FACTOR SF3B 49 KDA SUBUNIT). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.318821\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.280208957\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SF4\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0588972\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2944\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SPLICING FACTOR 4 ISOFORM B; RNA-BINDING PROTEIN. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.382047\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.154162184\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SFPQ\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.263446\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1672\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"SPLICING FACTOR, PROLINE-AND GLUTAMINE-RICH (POLYPYRIMIDINE TRACT- BINDING PROTEIN-ASSOCIATED SPLICING FACTOR) (PTB-ASSOCIATED SPLICING FACTOR) (PSF) (DNA-BINDING P52/P100 COMPLEX, 100 KDA SUBUNIT). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10501\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.238410512\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SFRS1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0238444\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1685\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"SPLICING FACTOR, ARGININE/SERINE-RICH 1 (PRE-MRNA SPLICING FACTOR SF2, P33 SUBUNIT) (ALTERNATIVE SPLICING FACTOR ASF-1). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.100146\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.238096379\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SFRS10\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.368948\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
412\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ARGININE/SERINE-RICH SPLICING FACTOR 10 (TRANSFORMER-2-BETA) (HTRA2- BETA) (TRANSFORMER 2 PROTEIN HOMOLOG) (SILICA-INDUCED PROTEIN 41) (RA301). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.32916\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.277579825\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SFRS11\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.148259\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
901\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SPLICING FACTOR ARGININE/SERINE-RICH 11 (ARGININE-RICH 54 KDA NUCLEAR PROTEIN) (P54). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.571608\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.259371807\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SFRS18\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.479679\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
848\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SR RICH PROTEIN. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.84052\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.260621455\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SFRS3\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.280063\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
638\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"SPLICING FACTOR, ARGININE/SERINE-RICH 3 (PRE-MRNA SPLICING FACTOR SRP20) (X16 PROTEIN). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04414\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.26822361\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SFRS8\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.155587\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1121\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"SPLICING FACTOR, ARGININE/SERINE-RICH 8 (SUPPRESSOR OF WHITE APRICOT PROTEIN HOMOLOG). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.620608\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.250700926\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SFT2D3\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.105333\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
673\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.394979\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.266680001\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SGCD\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0630725\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1878\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
DELTA-SARCOGLYCAN (SG-DELTA) (35 KDA DYSTROPHIN-ASSOCIATED GLYCOPROTEIN) (35DAG). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.270962\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.232772492\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SGCG\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0566858\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1877\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
GAMMA-SARCOGLYCAN (GAMMA-SG) (35 KDA DYSTROPHIN-ASSOCIATED GLYCOPROTEIN) (35DAG). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.243524\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.232772951\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SGCZ\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0628075\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1876\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SARCOGLYCAN ZETA; ZETA-SARCOGLYCAN. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.269823\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.232772966\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
SGPL1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0601623\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2114\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SPHINGOSINE-1-PHOSPHATE LYASE 1; SPHINGOSINE-1-PHOSPHATE LYASE. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.263668\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.228174447\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/